BGM Group (BGM, Financial) has announced a definitive agreement to acquire Wonder Dragon Global, marking a significant expansion in its health product offerings. The acquisition involves BGM issuing 38,165,290 Class A ordinary shares at $2 each, equating to a total valuation of RMB550 million. The transaction is set to conclude by the second quarter of 2025.
Wonder Dragon Global holds more than 3,000 metric tons of premium Qingzhuan dark tea, including 1,670 metric tons of raw materials and 1,350 metric tons of finished goods. This collection is valued for its medicinal properties and historical significance, providing a robust platform for BGM's research and development initiatives.
This strategic move is designed to bolster BGM Group's presence in the healthcare sector by enhancing its product lineup and extending market penetration. Known for its commitment to modernizing traditional industries, BGM has been integrating AI technology, big data analytics, and biopharmaceutical innovations into its operations. Post-acquisition, the company aims to improve tea production processes, increase product adaptability, and fast-track the creation of medicinal active ingredients utilizing its advanced AI-powered decision-making platform.
